You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Musculoskeletal conditions
  5. Arthritis

Secukinumab for treating active ankylosing spondylitis

  • Technology appraisal guidance
  • Reference number: TA407
  • Published:  28 September 2016
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History
Download guidance (PDF)
  • Overview
  • 1 Recommendations
  • 2 Information on secukinumab
  • 3 Evidence
  • 4 Committee discussion
  • 5 Implementation
  • 6 Appraisal committee members and NICE project team
  • 7 Update information

7 Update information

December 2025: We have made minor editorial changes to the wording in section 1.1 to align with the NICE guideline on spondyloarthritis in over 16s: diagnosis and management. This does not affect the meaning or intent of the guidance.

ISBN: 978-1-4731-2080-8


Previous page 6 Appraisal committee members and NICE project team
Back to top